WTC First Responders Have Higher Frequency of Gene Mutations Linked with Cancers

Amit Verma, M.B.B.S., discusses his study that found first responders who were at the World Trade Center on 9/11 have two to three times the number of blood cell mutations that are linked to leukemia, heart attacks, diabetes, and asthma compared to first responders who were not at the site. Dr. Verma is associate director for translational science at the NCI-designated Albert Einstein Cancer Center, professor of medicine and of developmental and molecular biology  at Einstein, and director of hemato-oncology at Montefiore.

Additional coverage includes MedPage Today, Boston Herald, ASCO Post

COVID-19 Vaccines ARE Effective in Cancer Patients

Balazs Halmos, M.D., and Amit Verma, M.B.B.S., comment on their study that finds patients with cancer developed antibodies to COVID-19 after vaccination. Dr. Halmos is director of the Multidisciplinary Thoracic Oncology Program at Montefiore and professor of medicine at Einstein; Dr. Verma is associate director of translational science at the Albert Einstein Cancer Center and director of the division of hemato-oncology at Montefiore.

More Evidence Firefighters Risk Cancer from 9/11 Exposure

A study by David Prezant, M.D., Amit Verma, M.B.B.S., and others finds that firefighters exposed to the 9/11 World Trade Center disaster site face an increased risk for a blood cancer precursor. Dr. Prezant is professor of medicine at Einstein, a pulmonary disease specialist at Montefiore and chief medical officer of the FDNY; Dr. Verma is professor of medicine at Einstein and director of hematologic malignancies at the Montefiore Einstein Center for Cancer Care.

More coverage on this story

MedPage Today
Los Angeles Times
Popular Science
Washington Times
Daily Mail
UPI (via HealthDay)
The ASCO Post